Business & regional news

The renewed partnership builds on over 30 years of collaboration

Medtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of the VitalFlow ECMO System

IRCAD North America is a first-of-its-kind education and training destination in the U.S.

Customers are being asked to remove the affected devices from use and replace with an alternate means of ventilation

Large, international registry designed to expand real-world data for Symplicity blood pressure procedure for uncontrolled hypertension

Minimally invasive laser technology now with enhanced capital system improvements, offering new user interface, workflow efficiencies, and upgrade capabilities

Regulatory review process to give patients better access to innovation through expedited development, assessment, and review of investigational Nellcor™ technology

Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its...

Medtronic, a global leader in healthcare technology, announced today that it has received CE (Conformité Européenne) Mark approval for several expanded indications for the treatment of coronary...

The Medtronic TAVI indication builds upon commitment to provide best in class patient outcomes today and enabling lifetime management solutions for the future

Installed for the first time in Korea at Seoul National University Hospital… Treatment, research, and education using Hugo to be fully launched in Korea Hugo RAS system expected to be utilized...

Collaboration introduces the Dragonfly™* technology to U.S. market, designed to enhance stone clearance, enable larger biopsy samples, and improve precision in biliary and pancreatic duct procedures

Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease

With its advanced multi-beat hemodynamic algorithm, the Argos™ monitor expands the parameters in the Medtronic perioperative portfolio

New investigational energy waveforms created specifically to target ventricular arrhythmias

Ventricular arrhythmia research will provide important clinical evidence using a new technology for patient population in need of new treatment options

Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.

Company honored for its pulsed field ablation technologies to treat atrial fibrillation

Annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs

Data from the largest study comparing drug-coated balloons presented as a late-breaking clinical trial at Cardiovascular Research Technologies 2025

The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetes

Taking the patient experience to the next stage

• Medtronic Spark will provide young people from low-income households the skills needed for well-paying jobs in a growing industry facing a global workforce shortage
• Initiative will address key workforce gaps in global healthcare and technology industries, which will face a combined talent shortage of 15 million by 2030

St. Francis Hospital in New York performs the first patient procedure in clinical trial for coronary artery disease

New report from Sperling’s BestPlaces and Medtronic highlights the cities they may call home

Women are less likely than men to receive post-stroke cardiac monitoring according to a new analysis unveiled at the International Stroke Conference 2025

Annual list measures reputation of the world’s leading organizations

Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains

Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations

Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter

Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally

Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion

DEFINE AFib results at AF Symposium 2025: First-of-its-kind app-based study uses AF burden data to identify patients at high risk for AF-related healthcare utilization

LINQ™ insertable cardiac monitors showed 4 times greater episode sensitivity compared to Apple Watch™*

Medtronic, a global leader in healthcare technology, announced that it has received the prestigious Great Place to Work® certification in the mid-size organization...

Agreement includes option to acquire the company

Harmony™ Transcatheter Pulmonary Valve system approval expands minimally invasive treatment options for patients with congenital heart disease across European Union

Patients can access advanced gastrointestinal care either in clinical settings or from the comfort of their home.

Two data releases at London Valves 2024 build on Evolut’s legacy of valve design and performance: Optimize PRO study demonstrates improved procedure efficiencies and valve performance Pooled...

Additional GI Genius™ units installed at VA facilities, providing enhanced colonoscopy care and advancing AI-powered diagnostics for veterans

Endoflip™ is an advanced diagnostic tool that can help expedite accurate diagnosis of esophageal motility disorders, conditions often missed during endoscopies.^1,2

Collaboration with health technology company Tempus seeks to identify causes for undertreatment of minority patients with heart valve disease who may benefit from minimally invasive therapies

With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.

New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.